Articles dans des revues avec comité de lecture (44)
13.
Arsenijevic, T., Grégoire, F., Delforge, V., Delporte, C., & Perret, J. (2012). Murine 3T3-L1 adipocyte cell differentiation model: validated reference genes for qPCR gene expression analysis. PloS one, 7(5), e37517. doi:10.1371/journal.pone.003751714.
De Vriese, C., Hacquebard, M., Grégoire, F., Carpentier, Y., & Delporte, C. (2007). Ghrelin interacts with human plasma lipoproteins. Endocrinology, 148(5), 2355-2362. doi:10.1210/en.2006-128115.
De Vriese, C., Grégoire, F., De Neef, P., Robberecht, P., & Delporte, C. (2005). Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation. Endocrinology, 146(3), 1514-1522. doi:10.1210/en.2004-096416.
Migeotte, I., Riboldi, E., Franssen, J.-D., Grégoire, F., Loison, C., Wittamer, V., Detheux, M., Robberecht, P., Costagliola, S., Vassart, G., Sozzani, S., Parmentier, M., & Communi, D. (2005). Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. The Journal of Experimental Medicine, 201(1), 83-93. doi:10.1084/jem.2004127717.
De Vriese, C., Grégoire, F., Lema Kisoka, R., Waelbroeck, M., Robberecht, P., & Delporte, C. (2004). Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology, 145(11), 4997-5005. doi:10.1210/en.2004-056918.
Van Craenenbroeck, M., Grégoire, F., De Neef, P., Robberecht, P., & Perret, J. (2004). Ala-scan of ghrelin (1-14): Interaction with the recombinant human ghrelin receptor. Peptides, 25(6), 959-965. doi:10.1016/j.peptides.2004.03.01019.
Langer, I., Grégoire, F., Nachtergael, I., De Neef, P., Vertongen, P., & Robberecht, P. (2004). Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency. Peptides, 25(2), 275-278. doi:10.1016/j.peptides.2003.12.01320.
Wittamer, V., Grégoire, F., Robberecht, P., Vassart, G., Communi, D., & Parmentier, M. (2004). The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. The Journal of biological chemistry, 279(11), 9956-9962. doi:10.1074/jbc.M31301620021.
Langer, I., Vertongen, P., Perret, J., Cnudde, J., Grégoire, F., De Neef, P., Robberecht, P., & Waelbroeck, M. (2002). VPAC(1) receptors have different agonist efficacy profiles on membrane and intact cells. Cellular signalling, 14(8), 689-694.22.
Perret, J., Van Craenenbroeck, M., Langer, I., Vertongen, P., Grégoire, F., Robberecht, P., & Waelbroeck, M. (2002). Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue. Biochemical journal, 362(Pt 2), 389-394.23.
Dumas, R., Egberts, J. F. M., Stiekema, J. C. J., Woitinas, F., Kutnowski, M., Nikolic, I., Berberich, R., Abedinpour, F., Zoeckler, S., Grégoire, F., & Jerkovic, M. (1994). A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Age and ageing, 23(6), 512-516. doi:10.1093/ageing/23.6.51224.
Braekman, J. C., Daloze, D., Grégoire, F., Popov, S., & van Soest, R. (1994). Two new kalihinenes from the marine sponge Acanthella cavernosa. Bulletin des sociétés chimiques belges, 103(5-6), 187-191. doi:10.1002/bscb.19941030504